THE NOVO NORDISK UK RESEARCH FOUNDATION
* Promoting research into the causes and treatment of diabetes mellitus and publishing the useful result thereof.* The preservation and protection of the health of the public by educating them and conducting research into the causes and prevention of diabetes.* The advancement and promotion of education in the treatment of diabetes by members of the medical profession.
Financial health, per its FY2025 accounts
The accounts state that unrestricted reserves increased to £183,676, which the trustees consider sufficient to cover a year's expenditure. However, the filing notes that funding has only been secured through 2026, with no confirmation for 2027 or subsequent years, leading to a cessation of new awards from 2027 onwards.
What the accounts disclose
“In 2025, £295,000 was received from the charity's sole donor, Novo Nordisk Limited” — page 4
“It is the policy of the charity to maintain a sufficient cash balance to cover expenditure for a year.”
“The trustees have not secured funding for 2027 or subsequent years and therefore will not be advertising awards for 2026 to ensure the Foundation has the funds to meet its existing award commitments.” — page 10
“From 21 April 2025 the secretary took over the administration for the charity under a contract of employment with Novo Nordisk Limited. The associated costs have been recognised in the accounts as a donated service.” — page 4
“In 2025, £295,000 was received from the charity's sole donor, Novo Nordisk Limited” — page 4
“From 21 April 2025 the secretary took over the administration for the charity under a contract of employment with Novo Nordisk Limited. The associated costs have been recognised in the accounts as a donated service.” — page 4
“In 2025, £295,000 was received from the charity's sole donor, Novo Nordisk Limited” — page 4
“From 21 April 2025 the secretary took over the administration for the charity under a contract of employment with Novo Nordisk Limited. The associated costs have been recognised in the accounts as a donated service.” — page 4
“In 2025, £295,000 was received from the charity's sole donor, Novo Nordisk Limited” — page 4
Year-over-year changes
- Going concern: no going-concern doubt (FY2024) → going-concern doubt noted (FY2025).
Trustees
- Dr Danijela Tatovic
- Dr Dinesh Selvarajah
- Hannah Beba
- Nicholas Raymond Cahm
- Professor Pratik Choudhary
- Professor Richard Holt
- Professor Shareen Forbes
- Professor Steve Luzio
- Sandra Mulrennan
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £331k | £169k |
| 31/12/2024 | £387k | £285k |
| 31/12/2023 | £273k | £322k |
| 31/12/2022 | £272k | £327k |
| 31/12/2021 | £255k | £222k |
Common questions
Is THE NOVO NORDISK UK RESEARCH FOUNDATION financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted reserves increased to £183,676, which the trustees consider sufficient to cover a year's expenditure. However, the filing notes that funding has only been secured through 2026, with no confirmation for 2027 or subsequent years, leading to a cessation of new awards from 2027 onwards. Its FY2025 accounts were independently examined.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| ROBERT LUFF FOUNDATION LIMITED | 2 | £95k |
| SIR SAMUEL SCOTT OF YEWS TRUST | 2 | £30k |
| THE INMAN CHARITY | 2 | £12k |
| CECIL PILKINGTON CHARITABLE TRUST | 2 | £8k |
| THE IAN ASKEW CHARITABLE TRUST | 2 | £4k |
| GOWLING WLG (UK) CHARITABLE TRUST | 2 | £600 |
| REUBEN FOUNDATION | 1 | £121k |
| THE ALBERT GUBAY CHARITABLE FOUNDATION | 1 | £100k |
Charities like this
- THE INSULIN DEPENDENT DIABETES TRUST
- PRIMARY CARE DIABETES SOCIETY
- THE KIDNEY FUND
- DIABETES CARE TRUST (ABCD) LIMITED
- JUVENILE DIABETES RESEARCH FOUNDATION LIMITED
- THE BRITISH DIABETIC ASSOCIATION
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| THE NOVO NORDISK UK RESEARCH FOUNDATION | £331k | — | 0 | unclear | — | noted |
| THE INSULIN DEPENDENT DIABETES TRUST | £476k | — | 0 | unclear | — | no doubt |
| PRIMARY CARE DIABETES SOCIETY | £169k | — | 0 | unclear | — | no doubt |
| THE KIDNEY FUND | £297k | — | 0 | unclear | — | no doubt |
| DIABETES CARE TRUST (ABCD) LIMITED | £391k | £40,568.10 | — | above | — | no doubt |
| JUVENILE DIABETES RESEARCH FOUNDATION LIMITED | £8.0m | — | — | below | — | no doubt |